Clinical outcome of patients with acute myocardial infarction randomized to either coronary stenting plus abciximab or fibrinolysis plus abciximab (STOPAMI-2 Trial)

Autor:	Julinda Mehilli, Markus Schwaiger, Melchior Seyfarth, Ullrich Schricke, Josef Dirschinger, Jodi Neverve, Franz-Josef Neumann, Adnan Kastrati, Jürgen Pache, Stefan Martinoff, Albert Schoemig, Rudolf Blasini, Stephan G. Nekolla
Rok vydání:	2002
Předmět:	medicine.medical_specialty business.industry medicine.medical_treatment Coronary stenting medicine.disease Internal medicine Fibrinolysis Abciximab Cardiology Medicine cardiovascular diseases Myocardial infarction business Cardiology and Cardiovascular Medicine medicine.drug
Zdroj:	Journal of the American College of Cardiology. 39:295-296
ISSN:	0735-1097
DOI:	10.1016/s0735-1097(02)81327-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d31d65c4a8f507d1a53f146a35fca07 Zobrazit plný text záznamu